Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

Cost effectiveness of a test to detect metastases for endometrial cancer.

Havrilesky LJ, Maxwell GL, Chan JK, Myers ER.

Gynecol Oncol. 2009 Mar;112(3):526-30. doi: 10.1016/j.ygyno.2008.11.017. Epub 2008 Dec 18.

PMID:
19100608
2.

Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.

Cohn DE, Huh WK, Fowler JM, Straughn JM Jr.

Obstet Gynecol. 2007 Jun;109(6):1388-95.

PMID:
17540812
3.

Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.

Rankins NC, Secord AA, Jewell E, Havrilesky LJ, Soper JT, Myers E.

Gynecol Oncol. 2007 Aug;106(2):388-93. Epub 2007 May 16.

PMID:
17509672
4.

Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.

Jewell EL, Kulasingam S, Myers ER, Alvarez Secord A, Havrilesky LJ.

Gynecol Oncol. 2007 Dec;107(3):532-40. Epub 2007 Sep 27.

PMID:
17900674
5.

Cost-effectiveness of deep venous thrombosis prophylaxis in gynecologic oncology surgery.

Maxwell GL, Myers ER, Clarke-Pearson DL.

Obstet Gynecol. 2000 Feb;95(2):206-14.

PMID:
10674581
6.

Cost-effectiveness of treatment of early stage endometrial cancer.

Ashih H, Gustilo-Ashby T, Myers ER, Andrews J, Clarke-Pearson DL, Berry D, Berchuck A.

Gynecol Oncol. 1999 Aug;74(2):208-16.

PMID:
10419733
7.

Modelling the cost-effectiveness of sentinel lymph node mapping and adjuvant interferon treatment for stage II melanoma.

Wilson LS, Reyes CM, Lu C, Lu M, Yen C.

Melanoma Res. 2002 Dec;12(6):607-17.

PMID:
12459651
8.

Cost-effectiveness analysis of endometrial cancer prevention strategies for obese women.

Kwon JS, Lu KH.

Obstet Gynecol. 2008 Jul;112(1):56-63. doi: 10.1097/AOG.0b013e31817d53a4.

PMID:
18591308
9.

Lynch syndrome screening strategies among newly diagnosed endometrial cancer patients.

Resnick K, Straughn JM Jr, Backes F, Hampel H, Matthews KS, Cohn DE.

Obstet Gynecol. 2009 Sep;114(3):530-6. doi: 10.1097/AOG.0b013e3181b11ecc.

PMID:
19701031
10.

Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?

Havrilesky LJ, Sanders GD, Kulasingam S, Myers ER.

Gynecol Oncol. 2008 Nov;111(2):179-87. doi: 10.1016/j.ygyno.2008.07.006. Epub 2008 Aug 21.

PMID:
18722004
11.

Investigating postmenopausal bleeding for endometrial cancer: cost-effectiveness of initial diagnostic strategies.

Clark TJ, Barton PM, Coomarasamy A, Gupta JK, Khan KS.

BJOG. 2006 May;113(5):502-10.

12.

Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?

Clements AE, Tierney BJ, Cohn DE, Straughn JM Jr.

Gynecol Oncol. 2013 Feb;128(2):166-70. doi: 10.1016/j.ygyno.2012.10.007. Epub 2012 Oct 16.

PMID:
23078763
13.

Cost effectiveness of risk-prediction tools in selecting patients for immediate post-prostatectomy treatment.

Zubek VB, Konski A.

Mol Diagn Ther. 2009;13(1):31-47. doi: 10.2165/01250444-200913010-00006.

PMID:
19351214
14.

Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.

Fanning J, Hoffman ML, Andrews SJ, Harrah AW, Feldmeier JJ.

Gynecol Oncol. 2004 Jun;93(3):632-6.

PMID:
15196856
15.

Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes.

Hoekstra A, Singh DK, Garb M, Arekapudi S, Rademaker A, Lurain JR.

Gynecol Oncol. 2006 Dec;103(3):897-901. Epub 2006 Jun 30.

PMID:
16814370
16.

Treatment for early endometrial cancer. Cost-effectiveness analysis.

Fanning J.

J Reprod Med. 1999 Aug;44(8):719-23.

PMID:
10483543
17.
18.

Cost-effectiveness analysis of annual screening strategies for endometrial cancer.

Havrilesky LJ, Maxwell GL, Myers ER.

Am J Obstet Gynecol. 2009 Jun;200(6):640.e1-8. doi: 10.1016/j.ajog.2009.02.022. Epub 2009 Apr 19.

PMID:
19380121
19.

Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance.

Bristow RE, Purinton SC, Santillan A, Diaz-Montes TP, Gardner GJ, Giuntoli RL 2nd.

Gynecol Oncol. 2006 Nov;103(2):709-13. Epub 2006 Jun 23.

PMID:
16797686
20.

Cost-effectiveness of the 70-gene signature versus St. Gallen guidelines and Adjuvant Online for early breast cancer.

Retèl VP, Joore MA, Knauer M, Linn SC, Hauptmann M, Harten WH.

Eur J Cancer. 2010 May;46(8):1382-91. doi: 10.1016/j.ejca.2010.02.035. Epub 2010 Mar 30.

PMID:
20359886

Supplemental Content

Support Center